House lawmakers advanced the bill to cap insulin and related medical supplies at $25 per month each with a 59-27 vote.
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
A federal judge in Missouri rejected three major pharmacy benefit managers’ push to pause the Federal Trade Commission’s ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
More than 7,500 students with Type 1 diabetes enter college every year, and the number is only growing. At the University of ...
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback